Chloe Shay

1.4k total citations · 1 hit paper
33 papers, 904 citations indexed

About

Chloe Shay is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chloe Shay has authored 33 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Chloe Shay's work include Cancer, Hypoxia, and Metabolism (7 papers), Protein Degradation and Inhibitors (6 papers) and Fibroblast Growth Factor Research (5 papers). Chloe Shay is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Protein Degradation and Inhibitors (6 papers) and Fibroblast Growth Factor Research (5 papers). Chloe Shay collaborates with scholars based in United States, China and Georgia. Chloe Shay's co-authors include Yong Teng, Lixia Gao, Liwei Lang, Xiangdong Zhao, Nabil F. Saba, Austin Y. Shull, Yuanping Xiong, Xiuli Wang, Reid Loveless and Wenfa Zhang and has published in prestigious journals such as Cancer Research, Oncogene and Journal of Hematology & Oncology.

In The Last Decade

Chloe Shay

32 papers receiving 898 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer metabolism and carcinogenesis

2024 58 citations Chloe Shay, Nabil F. Saba et al. Experimental Hematology and Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chloe Shay United States	21	628	257	184	102	97	33	904
Yoelsis Garcia‐Mayea Spain	15	574 0.9×	315 1.2×	251 1.4×	97 1.0×	71 0.7×	17	823
Lei Xi China	13	504 0.8×	311 1.2×	228 1.2×	83 0.8×	81 0.8×	32	870
Cristina Mir Spain	14	547 0.9×	309 1.2×	245 1.3×	67 0.7×	74 0.8×	18	792
Luciana Rodrigues Gomes Brazil	13	457 0.7×	237 0.9×	193 1.0×	179 1.8×	108 1.1×	17	810
Alisha M. Mendonsa United States	7	478 0.8×	227 0.9×	268 1.5×	108 1.1×	89 0.9×	8	865
Sima Orouei Iran	16	571 0.9×	379 1.5×	167 0.9×	75 0.7×	89 0.9×	19	848
Beomseok Son South Korea	15	398 0.6×	228 0.9×	181 1.0×	59 0.6×	116 1.2×	23	767
Shilei Tang China	13	596 0.9×	365 1.4×	102 0.6×	60 0.6×	148 1.5×	15	810

Countries citing papers authored by Chloe Shay

Since Specialization

Citations

This map shows the geographic impact of Chloe Shay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloe Shay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloe Shay more than expected).

Fields of papers citing papers by Chloe Shay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloe Shay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloe Shay. The network helps show where Chloe Shay may publish in the future.

Co-authorship network of co-authors of Chloe Shay

This figure shows the co-authorship network connecting the top 25 collaborators of Chloe Shay. A scholar is included among the top collaborators of Chloe Shay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloe Shay. Chloe Shay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Sijia, et al.. (2025). Tumor secretome shapes the immune landscape during cancer progression. Journal of Experimental & Clinical Cancer Research. 44(1). 47–47. 7 indexed citations

Shay, Chloe, et al.. (2024). Cancer metabolism and carcinogenesis. Experimental Hematology and Oncology. 13(1). 10–10. 58 indexed citations breakdown →

Gao, Lixia, Chloe Shay, & Yong Teng. (2024). Cell death shapes cancer immunity: spotlighting PANoptosis. Journal of Experimental & Clinical Cancer Research. 43(1). 168–168. 31 indexed citations

Lang, Liwei, Fanghui Chen, Yamin Li, et al.. (2023). Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer. Cancer Research Communications. 3(4). 659–671. 10 indexed citations

Yang, Fan, et al.. (2023). Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States. Journal of Experimental & Clinical Cancer Research. 42(1). 4–4. 40 indexed citations

Lang, Liwei, Reid Loveless, Juan Dou, et al.. (2022). ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development. Journal of Experimental & Clinical Cancer Research. 41(1). 43–43. 25 indexed citations

Loveless, Reid, Chloe Shay, & Yong Teng. (2021). Unveiling Tumor Microenvironment Interactions Using Zebrafish Models. Frontiers in Molecular Biosciences. 7. 611847–611847. 3 indexed citations

Shay, Chloe, et al.. (2021). Multifaceted Roles of Long Non-coding RNAs in Head and Neck Cancer. Advances in experimental medicine and biology. 1286. 107–114. 1 indexed citations

Lang, Liwei, Fang Wang, Zhi‐Chun Ding, et al.. (2021). Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 393–393. 33 indexed citations

10.

Shay, Chloe, et al.. (2020). PI3K Isoform-Selective Inhibitors in Cancer. Advances in experimental medicine and biology. 1255. 165–173. 9 indexed citations

11.

Gao, Lixia, et al.. (2020). Targeting ROS-Mediated Crosstalk Between Autophagy and Apoptosis in Cancer. Advances in experimental medicine and biology. 1260. 1–12. 104 indexed citations

12.

Teng, Yong, Liwei Lang, & Chloe Shay. (2019). ATAD3A on the Path to Cancer. Advances in experimental medicine and biology. 1134. 259–269. 17 indexed citations

13.

Xiong, Yuanping, Leilei He, Chloe Shay, et al.. (2019). Nck-associated protein 1 associates with HSP90 to drive metastasis in human non-small-cell lung cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 122–122. 37 indexed citations

14.

Lang, Liwei, Chloe Shay, Xiangdong Zhao, et al.. (2019). Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma. Journal of Hematology & Oncology. 12(1). 132–132. 32 indexed citations

15.

Lang, Liwei, et al.. (2019). PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell Metabolism. Advances in experimental medicine and biology. 1134. 243–258. 47 indexed citations

16.

He, Leilei, Lixia Gao, Chloe Shay, et al.. (2019). Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis. Journal of Experimental & Clinical Cancer Research. 38(1). 84–84. 35 indexed citations

17.

Lang, Liwei, et al.. (2018). Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib. Journal of Hematology & Oncology. 11(1). 85–85. 40 indexed citations

18.

Teng, Yong, Huakan Zhao, Lixia Gao, et al.. (2017). FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4–GSK3β–Nrf2 Signaling. Cancer Research. 77(22). 6215–6225. 70 indexed citations

19.

Teng, Yong, Yafei Cai, Wenhu Pi, Lixia Gao, & Chloe Shay. (2017). Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity. Journal of Hematology & Oncology. 10(1). 118–118. 20 indexed citations

20.

Gao, Lixia, Chloe Shay, Fenglin Lv, Xiuli Wang, & Yong Teng. (2017). Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short report. Cellular Oncology. 41(1). 85–91. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoelsis Garcia‐Mayea Breakdown of academic impact, for papers by Lei Xi Breakdown of academic impact, for papers by Cristina Mir Breakdown of academic impact, for papers by Luciana Rodrigues Gomes Breakdown of academic impact, for papers by Alisha M. Mendonsa Breakdown of academic impact, for papers by Sima Orouei Breakdown of academic impact, for papers by Beomseok Son Breakdown of academic impact, for papers by Shilei Tang